These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9477168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs.
    Kaburaki M, Narita H, Yabana H, Karasawa T, Doi H, Murata S.
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):240-7. PubMed ID: 9475265
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G, Iqbal A, Schwartz A, Vanhoutte PM.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation.
    Odawara A, Kikkawa K, Katoh M, Toryu H, Shimazaki T, Sasaki Y.
    Circ Res; 1996 Apr; 78(4):643-9. PubMed ID: 8635222
    [Abstract] [Full Text] [Related]

  • 7. Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis.
    Kaburaki M, Doi H, Narita H, Odawara A, Yasoshima A, Murata S.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):470-7. PubMed ID: 9514194
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
    Murata S, Kikkawa K, Yabana H, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
    [Abstract] [Full Text] [Related]

  • 9. Peripheral vasodilator and cardiac properties of the 1,5-benzothiazepine calcium antagonist analog, TA-3090, in dogs.
    Dumont L, Derouin M, Chartrand C, Archambeault P, Garceau D, Caillé G.
    Can J Physiol Pharmacol; 1991 Apr; 69(4):512-7. PubMed ID: 2059913
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and pharmacological properties of azido derivatives of 1,5-benzothiazepine Ca antagonist.
    Narita H, Gaino M, Suzuki T, Kurosawa H, Inoue H, Nagao T.
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):407-10. PubMed ID: 2337956
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia.
    Doi H, Kaburaki M, Inoue H, Suzumura K, Narita H.
    Jpn J Pharmacol; 2000 May; 83(1):73-81. PubMed ID: 10887943
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.
    Ohtsuka M, Ono T, Hiroi J, Esumi K, Kikuchi H, Kumada S.
    J Cardiovasc Pharmacol; 1983 May; 5(6):1074-82. PubMed ID: 6196557
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of the optically active trans-isomers of diltiazem and their cardiovascular effects and Ca-antagonistic activity.
    Tanaka T, Inoue H, Date T, Okamura K, Aoe K, Takeda M, Kugita H, Murata S, Yamaguchi T, Kikkawa K.
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1476-80. PubMed ID: 1394665
    [Abstract] [Full Text] [Related]

  • 14. Cerebral vasodilating and spasmolytic actions of a new Ca-antagonist, clentiazem (TA-3090), in anesthetized animals.
    Murata S, Kikkawa K, Nagao T.
    J Cardiovasc Pharmacol; 1992 May; 19(5):790-7. PubMed ID: 1381778
    [Abstract] [Full Text] [Related]

  • 15. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 16. Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric and femoral hemodynamics.
    Ishikawa H, Matsushima A, Matsui H, Shindo T, Morifuji T, Okabayashi M.
    Arzneimittelforschung; 1978 Apr; 28(3):400-2. PubMed ID: 580747
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 3. Hypotensive and antimyocardial-stunning effects in dogs.
    Kimoto S, Haruna M, Matsuura E, Uno O, Ishii M, Hirono S, Yoshimura K, Ueda M, Iwaki K.
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):180-7. PubMed ID: 9057066
    [Abstract] [Full Text] [Related]

  • 18. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 19. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
    Zobrist RH, Mecca TE.
    J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
    [Abstract] [Full Text] [Related]

  • 20. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
    Ikeda S, Oka J, Nagao T.
    Eur J Pharmacol; 1991 Nov 13; 208(3):199-205. PubMed ID: 1663043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.